L1, a highly conserved transmembrane glycoprotein member of the immunoglobulin superfamily of cell adhesion molecules, mediates many developmental processes in the nervous system. Here we present the biophysical characterization and the binding properties of the least structurally defined part of this receptor: its cytoplasmic tail (CT). We have shown by analytical ultracentrifugation and dynamic light scattering experiments that it is mostly monomeric and unstructured in aqueous solution. We have defined by nuclear magnetic resonance the molecular details of L1-CT binding to two major targets: a membrane-cytoskeletal linker (MCL), ezrin, and an endocytosis mediator, AP2. Surprisingly, in addition to the two previously identified ezrin binding motifs, the juxtamembrane and the 1176 YRSLE regions, we have discovered a third one, a part of which has been previously associated with binding to another MCL, ankyrin. For the L1 interaction with AP2 we have determined the precise interaction region surrounding the 1176 YRSLE binding site and that this overlaps with the second ezrin binding site. In addition, we have shown that the juxtamembrane region of L1-CT has some binding affinity to AP2-μ2, although the specificity of this interaction needs further investigation. These data indicate that L1-CT belongs to the class of intrinsically disordered proteins. Endogenous flexibility of L1-CT might play an important role in dynamic regulation of intracellular signaling: the ability of cytoplasmic tails to accommodate different targets has the potential to fine-tune signal transduction via cell surface receptors.A transmembrane glycoprotein member of the immunoglobulin superfamily of cell adhesion molecules (IgCAM), 1 L1 is essential for many developmental processes. Mutation of the single gene encoding L1 in humans results in a number of devastating neurological abnormalities and mental retardation syndromes (1). L1 involvement in the metastatic progression has been well documented, and it is now considered an important target for treating specific tumor types, including ovarian carcinomas (2). † This work was supported in parts by grants from the American Heart Association (0335075N) and the University of Connecticut The importance of understanding L1-CT oligomeric state comes from the notion that L1-mediated cell adhesion is associated with the activation of the MAP-kinase signaling pathway (3), the initial stages of which are characterized by L1 clustering. There are many classic examples, such as avidity modulation in integrins (4,5), showing that receptor oligomerization is an important initial step during activation. Any part of the receptor may be involved in this process. Recent studies indicate that the third fibronectin type III domain of the L1 extracellular domain spontaneously homomultimerizes, leading to the formation of trimeric L1 and the concomitant recruitment of integrins (6). The transmembrane domain of human L1 contains a potential homooligomerization motif, GXXXG (7). However its role in L1 cl...